Mineralys Therapeutics, Inc. (MLYS) Dividend History

Mineralys Therapeutics, Inc. (MLYS) is a biopharmaceutical company focused on developing therapies for cardiovascular and metabolic diseases. The company utilizes proprietary technology to develop targeted treatments aimed at addressing unmet medical needs, with a particular emphasis on hyperkalemia. Mineralys aims to advance innovative solutions to improve patient outcomes in these therapeutic areas.

150 N. Radnor Chester Road, Radnor, PA, 19087
Phone: (888) 378-6240
Website: https://mineralystx.com

Dividend History

Mineralys Therapeutics, Inc. currently does not pay dividends

Company News

  • Mineralys Therapeutics presented subgroup analyses from its Phase 3 Launch-HTN trial, demonstrating lorundrostat's efficacy in reducing blood pressure across diverse high-risk patient populations with uncontrolled hypertension, with consistent safety and meaningful clinical results.

    GlobeNewswire Inc.
  • Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. Compass Minerals Intl posted quarterly adjusted earnings of 5 cents per share, missing market estimates of 26 cents per share. The company’s quarterly sales came in at $341.70 million versus expectations of $357.90 million. Compass Minerals International shares fell 9% to $20.52 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Syra Health Corp. (NASDAQ: SYRA) shares jumped 310% to $4.71 after the company announced a partnership for a federal contract valued at $75 billion. Hitek Global Inc. (NASDAQ: HKIT) surged 305% to $4.6220 after jumping more than 60% on Wednesday. MicroAlgo Inc. (NASDAQ: MLGO) shares climbed 160% to $1.48. CCSC Technology International Holdings Limited (NASDAQ: CCTG) shares gained 90.3% to $4.9299 after falling 20% on Wednesday. U Power Limited (NASDAQ: UCAR) climbed 75% to $0.1153. The company appointed Jean Christophe von Pfetten as an independent director and a member of the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective February 1, 2024. WiMi Hologram Cloud Inc. (NASDAQ: WIMI) shares rose 53.3% to $1.2290 after gaining over 26% on Wednesday. Bit Brother Limited (NASDAQ: BETS) shares climbed 51.2% to $2.69 amid strength in Bitcoin. Arm Holdings plc (NASDAQ: ARM) shares climbed 47.3% to $113.41 after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. Zhongchao Inc. (NASDAQ: ZCMD) rose 41.5% to $0.4250. WeTrade Group, Inc. (NASDAQ: WETG) gained 38.6% to $3.05. Meiwu Technology Company Limited (NASDAQ: WNW) jumped 37% to $1.6205. Healthcare Triangle, Inc. (NASDAQ: HCTI) surged 36% to $3.8250. Oscar Health, Inc. (NYSE: OSCR) shares rose 21.2% to $16.27 after the company reported better-than-expected fourth-quarter financial results. Roma Green Finance Limited (NASDAQ: ROMA) shares gained 20.4% to $0.94 after declining over 5% on Wednesday. Mineralys Therapeutics, Inc. (NASDAQ: MLYS) surged 18.5% to $14.77. Mineralys Therapeutics announced ...

    Benzinga
  • Mineralys Therapeutics, Inc. (MLYS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    Zacks Investment Research
  • After the Q1 installment covering large-cap and mid-cap insider activity, we focus on the small-cap range. See the small-cap stocks we consider research-worthy.

    Seeking Alpha
Page data last updated 09/07/2025 04:17:14 UTC